As shown in Table 2, acute myeloid leukemia is prioritized as the most significant m6A associated disease, where m6A-regulated genes NSD1, PICALM, and ABL2 are OMIM-annotated disease genes, suggesting that they may be potential m6A-associated biomarkers in leukemia. Here, NSD1 is linked to leukemia.